HomeCompareQCCO vs JNJ

QCCO vs JNJ: Dividend Comparison 2026

QCCO yields 104.17% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QCCO wins by $4.58M in total portfolio value
10 years
QCCO
QCCO
● Live price
104.17%
Share price
$1.92
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.61M
Annual income
$1,596,885.34
Full QCCO calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — QCCO vs JNJ

📍 QCCO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQCCOJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QCCO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QCCO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QCCO
Annual income on $10K today (after 15% tax)
$8,854.17/yr
After 10yr DRIP, annual income (after tax)
$1,357,352.54/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, QCCO beats the other by $1,353,366.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QCCO + JNJ for your $10,000?

QCCO: 50%JNJ: 50%
100% JNJ50/50100% QCCO
Portfolio after 10yr
$2.32M
Annual income
$800,787.37/yr
Blended yield
34.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

QCCO
No analyst data
Altman Z
1.4
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QCCO buys
0
JNJ buys
0
No recent congressional trades found for QCCO or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQCCOJNJ
Forward yield104.17%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$4.61M$30.3K
Annual income after 10y$1,596,885.34$4,689.40
Total dividends collected$4.14M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: QCCO vs JNJ ($10,000, DRIP)

YearQCCO PortfolioQCCO Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$21,117$10,416.67$10,592$272.30+$10.5KQCCO
2$43,152$20,557.50$11,289$357.73+$31.9KQCCO
3$85,434$39,261.38$12,123$472.89+$73.3KQCCO
4$164,061$72,645.73$13,141$629.86+$150.9KQCCO
5$305,921$130,376.02$14,408$846.81+$291.5KQCCO
6$554,541$227,205.50$16,021$1,151.60+$538.5KQCCO
7$978,269$384,910.31$18,122$1,588.22+$960.1KQCCO
8$1,681,348$634,600.72$20,930$2,228.20+$1.66MQCCO
9$2,818,376$1,019,333.42$24,792$3,191.91+$2.79MQCCO
10$4,612,548$1,596,885.34$30,274$4,689.40+$4.58MQCCO

QCCO vs JNJ: Complete Analysis 2026

QCCOStock

QC Holdings, Inc. provide various financial services for consumers and small businesses in the United States and Canada. The company offers installment, deferred deposit, and title-collateralized loans; and check cashing, bill pay, wire transfer and money orders, debit card, and prepaid card services. It also provides online lending, equity-based financing for small business, and factoring services, as well as personal loans through online under the 310-LOAN brand. The company operates 250 retail location in the United States. QC Holdings, Inc. was founded in 1984 and is headquartered in Lenexa, Kansas.

Full QCCO Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this QCCO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QCCO vs SCHDQCCO vs JEPIQCCO vs OQCCO vs KOQCCO vs MAINQCCO vs ABBVQCCO vs MRKQCCO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.